Avid Bioservices, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Avid Bioservices supplements its proxy statement to address stockholder demands and lawsuits challenging the proposed merger with Space Finco, Inc., a subsidiary formed by affiliates of GHO Capital Partners LLP and Ampersand Management LLC.
Avid Bioservices reminds stockholders to vote in favor of the proposed acquisition by GHO Capital Partners LLP and Ampersand Capital Partners at the special meeting scheduled for January 30, 2025.
Avid Bioservices encourages stockholders to vote in favor of the proposed acquisition by GHO Capital Partners and Ampersand Capital Partners, supported by recommendations from ISS and Glass Lewis.
Avid Bioservices files an investor presentation highlighting the benefits of its proposed acquisition by GHO Capital Partners and Ampersand Capital Partners, urging stockholders to vote in favor of the transaction.
Avid Bioservices is set to be acquired by Space Finco, Inc., backed by GHO and Ampersand, for $12.50 per share in cash, representing a significant premium to its recent trading price.
DEFA14A: Avid Bioservices HSR Waiting Period Expires, Acquisition by GHO and Ampersand Nears Completion
Avid Bioservices announces the expiration of the Hart-Scott-Rodino waiting period, bringing its acquisition by GHO Capital Partners and Ampersand Capital Partners closer to completion.
DEFA14A: Avid Bioservices Recommends Stockholders Vote FOR Acquisition by GHO Capital and Ampersand Capital
Avid Bioservices urges stockholders to vote in favor of the proposed acquisition by GHO Capital Partners and Ampersand Capital Partners at $12.50 per share.
DEFM14A: Avid Bioservices to be Acquired by GHO Capital and Ampersand Capital Partners for $12.50 Per Share
Avid Bioservices is set to be acquired by funds managed by affiliates of GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 per share in cash.
Avid Bioservices has entered into a definitive agreement to be acquired by GHO Capital Partners and Ampersand Capital Partners for $12.50 per share in cash, valuing the transaction at $1.1 billion.
DEFA14A: Avid Bioservices to be Acquired by GHO Capital and Ampersand Capital Partners for $1.1 Billion
Avid Bioservices has entered into a definitive agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.
Avid Bioservices, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on October 16, 2024, with several key proposals up for vote.
Avid Bioservices is holding its 2024 annual meeting of stockholders on October 16, 2024, to vote on key proposals including the election of directors, ratification of the accounting firm, executive compensation, and amendments to stock incentive plans.